Drugplain

Yeztugo 300 mg/1

LENACAPAVIR SODIUM · TABLET, FILM COATED · Gilead Sciences, Inc.

No Recall History
Plain English

Yeztugo (lenacapavir sodium) is an oral prescription medication taken as a film-coated tablet that is used to treat HIV infection. It works by inhibiting HIV capsid function to help reduce viral load in patients with HIV.

Key Facts

Brand Name
Yeztugo
Generic Name
LENACAPAVIR SODIUM
NDC Code (Product)
61958-3401
Manufacturer
Gilead Sciences, Inc.
Strength
300 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA220020
Marketing Start
06/18/2025

Recall History

No Recall History

Frequently Asked Questions

What is Yeztugo used for?

Yeztugo (lenacapavir sodium) is an oral prescription medication taken as a film-coated tablet that is used to treat HIV infection. It works by inhibiting HIV capsid function to help reduce viral load in patients with HIV.

Is Yeztugo a controlled substance?

Yeztugo is not classified as a controlled substance by the DEA.

What is the generic name for Yeztugo?

The generic name for Yeztugo is LENACAPAVIR SODIUM. There are 3 other brand versions of LENACAPAVIR SODIUM.

What is the NDC code for Yeztugo 300 mg/1?

The NDC (National Drug Code) for Yeztugo 300 mg/1 is 61958-3401, listed by Gilead Sciences, Inc..

Product NDC

61958-3401

Package NDC

61958-3401-1

Other Yeztugo Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)